Intermittent Fasting Offers No Weight-Loss Advantage, New Evidence Shows

Overview

• Across 22 randomized trials with 1,995 adults, intermittent fasting did not produce a clinically meaningful weight-loss advantage over standard dietary counseling or increase the odds of losing at least five percent of body weight.
• The review notes mostly short trial durations, limited long-term data, participants largely from high‑income countries, no clear edge even versus no structured program, and side effects such as fatigue or headaches reported inconsistently.
• In a tightly controlled isocaloric crossover trial from DIfE and Charité, 31 overweight or obese women saw no improvements in blood glucose, insulin action, blood lipids, or inflammatory markers when eating identical calories in early (8–16) versus late (13–21) windows.
• Later eating shifted the biological clock by about 40 minutes and delayed sleep timing, as measured with a blood-based circadian phase test developed at Charité.
• Small weight changes reflected an estimated 170 kcal per day deficit, supporting authors’ conclusions that reported benefits in earlier fasting studies likely resulted from eating less, while experts urge caution for at‑risk groups and recommend gradual, gentler protocols.